Literature DB >> 23344765

Perioperative and long-term development of anxiety and depression in CABG patients.

B Korbmacher1, S Ulbrich, H Dalyanoglu, A Lichtenberg, J D Schipke, M Franz, R Schäfer.   

Abstract

BACKGROUND: The high incidence of symptomatic anxiety and depression in coronary artery bypass graft (CABG) patients may lead to impaired quality of life and increased morbidity and mortality. This prospective longitudinal study on CABG patients should provide data for future preoperative and postoperative psychotherapeutic interventions.
METHODS: From 2009 to 2010, 135 consecutive patients who were able and prepared were consulted by one interviewer immediately before 1  week (early) and 6 months (late) after surgery to complete the "Hospital Anxiety and Depression Scale" questionnaire.
RESULTS: Compared with the standard population, anxiety scores (AS) were preoperatively elevated in 39.3% of the patients. Early and late after surgery, AS had decreased to 34.4% (not significant [n.s.]) and 28.9% (p < 0.01). Before surgery, depression scores (DS) were elevated in 20.7%. Early and late after surgery, DS further increased to 24.0% (n.s.) and 28.0% (n.s.).Preoperative elevated DS appeared to correlate with increased complications. Mortality was not associated with elevated AS or DS. Both scores were not affected by on- or off-pump surgery.
CONCLUSION: Remarkably high AS and elevated DS late postoperatively require psychotherapeutic support even after seemingly successful CABG. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23344765     DOI: 10.1055/s-0032-1333326

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  8 in total

Review 1.  Psychological interventions for acute pain after open heart surgery.

Authors:  Susanne Ziehm; Jenny Rosendahl; Jürgen Barth; Bernhard M Strauss; Anja Mehnert; Susan Koranyi
Journal:  Cochrane Database Syst Rev       Date:  2017-07-12

2.  Psychosomatic background of classic cardiovascular risk factors.

Authors:  Bernhard Korbmacher; Ralf Schäfer
Journal:  Dtsch Arztebl Int       Date:  2012-10-26       Impact factor: 5.594

3.  Risk of depression after coronary artery bypass grafting: a SWEDEHEART population-based cohort study.

Authors:  Malin Stenman; Anders Jeppsson; Aldina Pivodic; Ulrik Sartipy; Susanne J Nielsen
Journal:  Eur Heart J Open       Date:  2022-03-02

4.  Anxiety, depression and stress among employees of a public higher education institution in São Paulo, Brazil.

Authors:  Isabela Maia da Cruz Fernandes; Amanda Mendes Ribeiro; Rayana Loch Gomes; Jaqueline Santos Silva Lopes; Luiz Carlos Marques Vanderlei; Roselene Modolo Regueiro Lorençoni
Journal:  Rev Bras Med Trab       Date:  2019-12-01

5.  Predicting poor postoperative acute pain outcome in adults: an international, multicentre database analysis of risk factors in 50,005 patients.

Authors:  Alexander Schnabel; Maryam Yahiaoui-Doktor; Winfried Meissner; Peter Konrad Zahn; Esther Miriam Pogatzki-Zahn
Journal:  Pain Rep       Date:  2020-07-27

6.  Cognitive behavioral therapy for depression improves pain and perceived control in cardiac surgery patients.

Authors:  Lynn V Doering; Anthony McGuire; Jo-Ann Eastwood; Belinda Chen; Rebecca C Bodán; Lawrence S Czer; Michael R Irwin
Journal:  Eur J Cardiovasc Nurs       Date:  2015-06-26       Impact factor: 3.908

7.  Surgery, stomas, and anxiety and depression in inflammatory bowel disease: a retrospective cohort analysis of privately insured patients.

Authors:  L A Sceats; M S Dehghan; K K Rumer; A Trickey; A M Morris; C Kin
Journal:  Colorectal Dis       Date:  2019-12-05       Impact factor: 3.788

Review 8.  Prevalence of Depression in Coronary Artery Bypass Surgery: A Systematic Review and Meta-Analysis.

Authors:  María Correa-Rodríguez; Moath Abu Ejheisheh; Nora Suleiman-Martos; María José Membrive-Jiménez; Almudena Velando-Soriano; Jacqueline Schmidt-RioValle; José Luis Gómez-Urquiza
Journal:  J Clin Med       Date:  2020-03-26       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.